Advanced search
Publication Cover
Postgraduate Medicine Volume 129, 2017 - Issue 3
Submit an article Journal homepage
184
Views
6
CrossRef citations to date
0
Altmetric
Clinical Features - Case Report

Eosinophilia as the presenting sign in pancreatic cancer: an extremely rare occurrence

Uroosa IbrahimDepartment of Hematology/Oncology, Staten Island University Hospital, Staten Island, NY, USACorrespondence[email protected]
View further author information
,
Divya AstiDepartment of Medicine, Staten Island University Hospital, Staten Island, NY, USAView further author information
,
Amina SaqibDepartment of Pulmonary/Critical Care Medicine, Staten Island University Hospital, Staten Island, NY, USAView further author information
,
Bindu Madhavi MudduluruDepartment of Medicine, Staten Island University Hospital, Staten Island, NY, USAView further author information
,
Sadaf AyazDepartment of Medicine, Staten Island University Hospital, Staten Island, NY, USAView further author information
&
Marcel OdaimiDepartment of Hematology/Oncology, Staten Island University Hospital, Staten Island, NY, USAView further author information
Pages 399-401 | Received 22 Jun 2016, Accepted 06 Oct 2016, Published online: 17 Oct 2016

References

  • American Cancer Society Pancreatic Cancer; 2015. [cited 2015 Dec 10]. Available from: http://www.cancer.org/cancer/pancreaticcancer/.
  • Anagnostopoulos GK, Sakorafas GH, Kostopoulos P, et al. Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF. J Surg Oncol. 2005;89:273–275.
  • Lowe D, Jorizzo J, Hutt MS. Tumour-associated eosinophilia: a review. J Clin Pathol. 1981;34:1243–1248.
  • Lowe D, Fletcher CD, Shaw MP, et al. Eosinophil infiltration in keratoacanthoma and squamous cell carcinoma of the skin. Histopathology. 1984;8:619–625.
  • Shepherd NA, Blackshaw AJ, Hall PA, et al. Malignant lymphoma with eosinophilia of the gastrointestinal tract. Histopathology. 1987;11:115–130.
  • Lowe D, Fletcher CD, Gower RL. Tumour-associated eosinophilia in the bladder. J Clin Pathol. 1984;37:500–502.
  • Ishibashi S, Ohashi Y, Suzuki T, et al. Tumor-associated tissue eosinophilia in human esophageal squa- mous cell carcinoma. Anticancer Res. 2006;26:1419–1424.
  • Ono Y, Ozawa M, Tamura Y, et al. Tumor-associated tissue eosinophilia of penile cancer. Int J Urol. 2002;9:82–87.
  • Wei Y-B, Yan B, Yin Z, et al. Chromophobe renal cell carcinoma associated with eosinophilia: A report of three cases. Exp Ther Med. 2014;8:91–94.
  • El-Osta H, El-Haddad P, Nabbout N. Lung carcinoma associated with excessive eosinophilia. J Clin Oncol. 2008;26:3456–3457.
  • Hirata J, Koga T, Nishimura J, et al. Pancreatic carcinoma associated with marked eosinophilia: a case report. Eur J Haematol. 1987;39:462–466.
  • Lammel V, Stoeckle C, Padberg B, et al. Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung. Lung Cancer. 2012;76:493–495.
  • Cormier SA, Taranova AG, Bedient C, et al. Pivotal advance: eosinophil infiltration of solid tumors is an early and persistent inflammatory host response. J Leukoc Biol. 2006;79:1131–1139.
  • Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2013;13:9–22.
  • Pandit R, Scholnik A, Wulfekuhler L, et al. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol. 2007;82:234–237.
  • Vassilatou E, Fisfis M, Morphopoulos G, et al. Papillary thyroid carcinoma producing granulocytemacrophage colony-stimulating factor is associated with neutrophilia and eosinophilia. Hormones. 2006;5:303–309.
  • Wilson TM I, Maric I, Shukla J. IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis. J Allergy Clin Immunol. 2011 Nov;128(5):1086-92.e1-3. doi:10.1016/j.jaci.2011.05.032
  • Di Sebastiano P I, Grottola T II, Di Mola FF. Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy. Updates Surg. 2016 Sep 15. doi:10.1007/s13304-016-0392-x
  • Ali A, Mokdad RM. Minter neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: a propensity score matched analysis. J Clin Oncol. 2016 Sep 12. pii: JCO685081. doi:10.1200/JCO.2016.68.5081

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.